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ABSTRACT: Membrane chromatography (MC) systems are
finding increasing use in downstream processing trains for
therapeutic proteins due to the unique mass-transfer
characteristics they provide. As a result, there is increased
need for model-based methods to scale-up MC units using
data collected on a scaled-down unit. Here, a strategy is
presented for MC unit scale-up using the zonal rate model
(ZRM). The ZRM partitions an MC unit into virtual flow
zones to account for deviations from ideal plug-flow
behavior. To permit scale-up, it is first configured for the
specific device geometry and flow profiles within the scaled-
down unit so as to achieve decoupling of flow and binding
related non-idealities. The ZRM is then configured for the
preparative-scale unit, which typically utilizes markedly
different flow manifolds and membrane architecture.
Breakthrough is first analyzed in both units under non-
binding conditions using an inexpensive tracer to indepen-
dently determine unit geometry related parameters of the
ZRM. Binding related parameters are then determined from
breakthrough data on the scaled-down MC capsule to
minimize sample requirements. Model-based scale-up may
then be performed to predict band broadening and
breakthrough curves on the preparative-scale unit. Here,
the approach is shown to be valid when the Pall XT140 and
XT5 capsules serve as the preparative and scaled-down units,
respectively. In this case, scale-up is facilitated by our finding
that the distribution of linear velocities through the
membrane in the XT140 capsule is independent of the feed
flow rate and the type of protein transmitted. Introduction of
this finding into the ZRM permits quantitative predictions of
breakthrough over a range of industrially relevant operating
conditions.
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Introduction
Membrane chromatography (MC) is increasingly used in
industry as an alternative purification platform to packed bed
chromatography (Boi et al., 2007; Ghosh, 2001; Ghosh and
Wong, 2006; Vogel et al., 2012). Due to larger pore sizes, slow
pore diffusion processes are essentially eliminated, leading to
higher mass-transfer rates, and reduced overall operational
times. The rate of column loading in a MC system is mainly
governed by protein convection and either the thermody-
namics or the rates of protein–sorbent complex formation
(Briefs and Kula, 1992; Charcosset, 2006; Suen and Etzel,
1994). However, it is known that column-loading profiles of
MC systems can deviate from the desired plug-flow behavior
and can be strongly asymmetrical in nature under certain
operating conditions (Montesinos-Cisneros et al., 2007;
Sarfert and Etzel, 1997; Yang and Etzel, 2003). Experimental
breakthrough curves (BTCs) typically show a sharp initial
breakthrough that is followed by a slow approach to
saturation. Such non-ideal behavior has been subject to
active research for many years.
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In the past, the asymmetric band broadening has been
attributed mainly to complex protein binding mechanisms.
These mechanisms have been modeled by many groups using
different hypotheses such as multi-site, spreading, random-
sequential adsorption, and steric mass-action/hindrance
isotherm or rate models (Boi et al., 2007; Briefs and
Kula, 1992; Brooks and Cramer, 1992; Clark et al., 2007;
Lundstrom, 1985; Suen and Etzel, 1992; Talbot et al., 2000).
In previous publications, we have shown that the spreading
model, which hypothesizes different binding orientations of
protein, can accurately describe the adsorption of bovine
serum albumin (BSA) and ovalbumin on polyethersulfone
membrane (PES) membranes coated with a cross-linked
polymer containing pendant Q groups (Francis et al.,
2011, 2012; Ghosh et al., 2013a). As well, Sarti and co-
workers have shown that the bi-Langmuir model can
accurately reproduce BTC data of BSA on cellulose acetate
surfaces (Dimartino et al., 2011).
In addition to non-ideal binding, it has been observed that
hold-up volumes within MC capsules, which are often as
large as the membrane volume itself, can contribute
significantly to system dispersion. This particularly holds
for low-volume lab-scale MC capsules with an axial flow
configuration, where solute molecules break through the
central membrane area much earlier than through outer
radial regions, and the resulting elution profiles can appear
highly dispersed (Ghosh and Wong, 2006). However, the
magnitude of these hold-up-volume related non-idealities
does not necessarily scale due to the often vastly different
manifold and membrane geometries used in scaled-down
and preparative-scale units. Indeed, we have previously
reported pronounced differences in band broadening within
lab-scale (Pall Mustang XT5 with 5mL membrane volume),
and preparative-scale (Pall Mustang XT140 with 140mL
membrane volume) MC capsules containing the same
membrane and operated at the same mean linear velocities
(Fig. 1) (Ghosh et al., 2013a). Variations in the manifold
design of the two MC capsules were identified as the major
cause of the observed non-linear scaling between these
capsules. Hence, any mathematical approach for model-
based analysis and scale-up of MC units must carefully
decouple the impacts of different non-idealities, including
those caused by protein binding and by manifold and
membrane architecture, on breakthrough performance.
We have previously developed a semi-empirical modeling
approach, the zonal rate model (ZRM) (Francis et al.,
2011, 2012; Ghosh et al., 2013a; von Lieres et al., 2009), for
decoupling the contributions to band broadening of non-
ideal hydrodynamics and binding in MC capsules. In the first
paper of this series, the ZRM was thereby applied to
systematically analyze lab-scale Mustang XT5 capsules. A
more limited study of the preparative-scale XT140 capsule
was also reported. Variations in protein residence times
within the inlet and elution manifolds of both units were
recorded, with the nature of the non-idealities unit-specific
due the different flow geometries employed. In addition,
variations in the linear velocity through the membrane stack
were recorded in the preparative-scale capsule due in part to
the radial-flow pleated membrane geometry employed.
Those latter variations were shown to impact BTCs under
binding conditions, while making relatively little contribu-
tion to band broadening under non-binding conditions.
Here, we show that the relative distribution of linear
velocities is independent of both the volumetric flow rate
and the characteristics of the transmitted protein. When this
knowledge is introduced into the ZRM, quantitative
prediction of protein BTCs within production-scale MC
capsules is then demonstrated over a range of industrially
relevant operating conditions. Predictions are based on
binding parameters determined in the scaled-down unit
yielding a new cost-effective model-based method for scale-
up and simulation of production-scale MC units.
Theory
Traditionally, MC has been modeled assuming flow
homogeneity (linear velocities and mean residence times)
within hold-up volumes upstream and downstream of the
membrane stack and also over membrane cross sections. The
hold-up volumes are therefore usually modeled by a linear
combination of one or two continuously stirred tank regions
(CSTR) and a plug flow region (PFR). The Roper and
Lightfoot model (RLM) captures system dispersion by
differently sized CSTRs on each side of the membrane
(Roper and Lightfoot, 1995). The RLM, although adequate
for modeling some cases, is based on a rather simplified
representation of the true physical geometry of these systems.
Zonal Rate Model
The ZRM is designed to quantitatively capture the impact of
inhomogeneous flow in MC capsules. To predict BTCs under
Figure 1. Breakthrough curves obtained under binding conditions for lab-scale
axial-flow and production-scale radial-flow MC capsules with 1mg/mL BSA at a flow
rate of 12MV/min.
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binding conditions, it requires a binding model, and the
Langmuir, steric mass action (SMA), and spreading models
have previously been integrated into the ZRM. A detailed
mathematical description of the ZRM can be found in
previous publications (Francis et al., 2011, 2012; von Lieres
et al., 2009). Here, we therefore only describe configurations
of the ZRM for the lab-scale Pall Mustang XT5 capsule (axial
flow, see Fig. 2a) and the production-scale Pall Mustang
XT140 capsule (radial flow, see Fig. 3a). Detailed information
on the internal geometry of both capsules has been reported
in a previous publication (Ghosh et al., 2013a). For the lab-
scale capsule, the ZRM conceptually partitions the hold-up
volumes before and after the membrane into two virtual flow
zones. The membrane stack is also partitioned into two
virtual zones having the same physical properties but subject
to different boundary conditions. The inter-connected
virtual zones for the hold-up volumes are modeled as a
CSTR network, while each of those within the membrane
stack are described by the one-dimensional mass continuity
equation of chromatography:
@c
@t
¼ v @c
@z
þ Da @
2c
@z2
 1 e
e
@q
@t
ð1Þ
Here c and q are the solute concentrations in the mobile and
stationary phases, respectively, z is the axial coordinate, v is
the interstitial fluid velocity, Da is the axial dispersion
coefficient, and e is the membrane porosity. We have
previously shown with the help of infrared spectroscopy that
the bulk porosity is rather homogeneous across the entire
cross-section and thickness of the membranes used in this
study (Johannes Kiefer et al., 2014). As is typical for
chromatography modeling, solution of Equation (1) requires
coupling to an appropriate protein-binding rate or isotherm
model (see Binding Kinetics). Finally, the ZRM adds a plug
flow region (PFR) in series with the CSTR network to model
any time lag that is not associated with system dispersion (the
time lag tlag¼VPFR/Q is the ratio of the PFR volume VPFR to
the volumetric feed flow rate Q):
coutðtÞ ¼ cinðt  tlagÞ ð2Þ
Due to its partitioning of the system into virtual zones, the
ZRM requires a set of flow fractions, Fk, which define the
fraction of the total volumetric flow passing through each of
the membrane zones (Fig. 2b). Solute dispersion in the
virtual zones upstream and downstream of the membrane
stack is described by a conventional CSTR equation
(t¼VCSTR/Q is the average residence time, and j is the
number of inflows of the respective CSTR):
@cout
@t
¼
Xm
j¼1
cin;j  cout
tj
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For the production-scale capsule, one virtual zone was
found to be sufficient for capturing the flow behavior in the
hold-up volumes before and behind the membrane region
(Fig. 3a) (Ghosh et al., 2013a). However, the membrane zone
had to be divided into several sectors with different linear
velocities (Fig. 3a, only three sectors are shown for clarity of
the sketch). These sectors represent specific regions of the
pleated membrane, each characterized by unique structural
attributes such as bed height and frontal area. Protein
transport in each sector of the membrane is computed by
solution of Equation (1) with the boundary conditions
remaining constant across sectors and the distribution of
linear velocities varying as a Gaussian-type function reported
in Figure 3b.
Figure 2. a: Virtual partitioning of hold-up volumes and membrane for the lab-
scale axial-flow capsule, and (b) flow fractions of the collecting tank downstream of
the membrane.
Figure 3. a: Virtual partitioning of hold-up volumes and membrane for the production-scale radial-flow capsule, where the membrane zone is split into sectors with varying
linear velocities, and (b) distribution of the relative volumetric flow, f, over the relative linear velocity, v, in the respective sector.
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Binding Kinetics
The kinetic form of the spreading model has been previously
shown to accurately correlate BTC data for BSA eluting from
a XT5 capsule (Francis et al., 2011, 2012; Ghosh et al., 2013a).
That model assumes two different bound states, yielding
rate equations of the form (Clark et al., 2007; Yang and
Etzel, 2003):
@q
@t
¼ @q1
@t
þ @q2
@t
ð4Þ
@q1
@t
¼ ðka;1c  k12q1Þðqm  q1  bq2Þ  kd;1q1 þ k21q2 ð5Þ
@q2
@t
¼ ðka;2c þ k12q1Þðqm  q1  bq2Þ  ðk21  kd;2Þq2 ð6Þ
Here q1 and q2 are the concentrations of bound states 1 and 2,
respectively, b is the ratio of the sorbent surface area occupied
by state 2 relative to state 1, ka,1, kd,1, ka,2, and kd,2 are binding
rate constants defined in analogy to the Langmuir model, and
k12 and k21 describe the rates of bound-state changes.
Materials and Methods
Bovine serum albumin (BSA, A 7638, Sigma–Aldrich Corp.,
St. Louis, MO) and ovalbumin (A 2512, Sigma–Aldrich
Corp.) were used for breakthrough experiments at a feed
concentration of 1 g/L. The protein was dissolved in 25mM
Tris buffer at pH 8.0 (Sigma–Aldrich Corp.) for the loading
step. Loading was followed by a 5–10 column-volume (CV)
washing step with 25mM Tris buffer at pH 8.0. Then, 1M
NaCl in 25mM Tris buffer pH 8.0 was used to elute the
bound protein from the membranes. The capsules were
cleaned with 1M NaCl after each run.
Mustang Q XT5 (axial flow, 5mL membrane volume) and
Mustang Q XT140 (radial flow, 140mL membrane volume)
anion-exchange membrane chromatography capsules were
purchased from Pall Inc. (East Hills, NY). Both capsules
contain modified hydrophilic polyethersulfone (PES) mem-
branes whose surfaces are coated with an irreversibly cross-
linked polymer that contains pendant Q groups. The average
effective bed height of the membrane stacks in the XT5 and
XT140 capsules is 2.20mm. The pore size and porosity e of the
membrane are 0.8mm and 0.70 0.05, respectively (manu-
facturer data). More details on the internal capsule geome-
tries, including a comprehensive MRI analysis, can be found
in a previous publication (Ghosh et al., 2013a). The XT5
capsule was attached to an ÄKTAexplorer system that was
controlled by the Unicorn software (GE Healthcare, Uppsala,
Sweden). The XT140 capsule was attached to an ÄKTAprocess
system that was controlled by the Unicorn software.
Results
In the first paper of this series, lab-scale MC capsules with an
axial flow configuration and production-scale MC capsules
with a radial flow configuration were comparatively analyzed
using 1mg/mL BSA at a flow rate of 12CV/min. Non-ideal
flow in the lab-scale capsule was effectively captured using a
two-zone configuration of the ZRM to describe BTC data
obtained under non-binding conditions. The membrane was
modeled using the same linear velocity in each zone, as
validated by an independent study employing computational
fluid dynamics (CFD) (Ghosh et al., 2013b). In contrast,
magnetic resonance imaging (MRI) data and CFD simulation
both revealed variations in the linear velocity within the
membrane stack in the production-scale capsule, and the
ZRM was correspondingly configured for describing this
capsule (Fig. 3). Several binding models were evaluated. A
simplified version of the spreading model, without adsorp-
tion/desorption from/to the second bound state, was found
to reproduce measured BTCs very well, and provides a
coherent explanation of the binding mechanism. Notably,
this binding model, combined with different configurations
of the ZRM, quantitatively describes BTC data at lab and
production scales with the samemodel parameters. However,
model-based scale-up (i.e., prediction of binding BTC data of
the production-scale capsule using parameters of the binding
model determined at lab scale) was not possible, in part due
to the fact that the linear velocity distribution in the
production-scale capsule could not be determined from non-
binding data.
Here, the linear velocity distribution in the membrane
stack of the XT140 capsule is studied as a function of the
volumetric flow rate (in membrane volumes per minute, the
XT5 and XT140 capsules contain 5 and 140mL ofmembrane,
respectively). Figure 3b shows that distribution at a flow rate
of 12MV/min. The validity of that distribution is demon-
strated through the fact that it was also predicted by CFD
simulations in an independent study (Ghosh et al., 2013b).
CFD simulations of the same capsule at flow rates of 1.2, 4,
and 5.7MV/min further reveal that the relative distribution
of linear flow rates through the membrane is independent of
the volumetric flow rate (data not shown). Figure 4 shows
Figure 4. Relative frequency, f, of linear velocities, v, through themembrane stack
at different volumetric flow rates through the production-scale capsule, as determined
by fitting a 16-sector ZRM to BTC data measured using BSA (1.2, 4, and 12MV/min) and
ovalbumin (5.7MV/min) under binding conditions.
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that the observed flow-rate-independent velocity distribu-
tion, in this case as determined experimentally from BTC
data measured under protein binding conditions, can be
accurately modeled using a ZRM configured with 16 sectors.
The experiments at 1.2 and 4MV/min were performed with
BSA as tracer molecule, while ovalbumin was used at 5.7MV/
min. As predicted by the CFD simulations, the experimen-
tally determined distributions are nearly super imposable,
though the width was seen to increase very slightly with
decreasing flow rate, likely due to measurement uncertainty.
As the effect is indeed quite small, the velocity distribution
measured at 12MV/min was used for all subsequent model
calculations, irrespective of the flow rate.
Model-Based Scale-Up for BSA
With the linear velocity distributions known, we asked
whether the ZRM could now be used to predict BTC data in
the production-scale XT140 capsule. To do this, BTC data for
BSA were collected in both the lab and production-scale
capsules as a function of feed flow rates.
With the ZRMconfigured using twomembrane zones with
the same linear velocity for the lab-scale capsule (Fig. 2), and
using onemembrane zone and 16 sectors with different linear
velocities for the production-scale capsule (Fig. 3), inhomo-
geneous flow in the hold-up volumes of each capsule was
analyzed by regressing the required PFR and CSTR
parameters to BTC data measured under non-binding
conditions at 1.2MV/min (Fig. 5a and b) and 4MV/min
(Fig. 6a and b). For both capsules, the configured ZRM
reproduces the BTC measured at both flow rates very well.
The regressed PFR and CSTR parameters, which are related
to the capsule geometry and independent of the binding
mechanism, are reported in Tables I and II. Notably, the
inverse values of the determined residence times approxi-
mately follow linear trends over flow rate. This could
technically be utilized for predicting these parameters at
different flow rates. However, individual determination of
these parameters from measurement data at the studied flow
rate has been found to yield more accurate results. With these
parameters known, the impact of protein binding on BTC
behavior in the lab-scale capsule could next be evaluated.
The spreading model was therefore combined with the
two-zone ZRM describing flow within the XT5 capsule.
Spreading model parameters for BSA binding were then
estimated from BTC data measured in that capsule under
binding conditions at flow rates of 1.2MV/min (Fig. 5c) and
4MV/min (Fig. 6c) and 12MV/min (Ghosh et al., 2013a). By
properly capturing the effects of flow non-idealities in the
XT5 capsule, the ZRM configured for that capsule accurately
reproduces the BTC at each flow condition. In Table III, the
estimated spreading model parameters are reported as a
function of flow rate. Each parameter is practically flow rate
independent, except for the binding constant ka,1. Taking
averages of the k21 and qm values observed across flow rates
would cause negligible changes in model predictions (data
not shown). The initial adsorption rate 1/(ka,1 · Qm)¼ 0.37 s
(1.2MV/min), 0.13 s (4MV/min), and 0.042 s (12MV/min)
is always fast, but increases with flow rate, suggesting either
that the protein’s surface energy (e.g., conformation) changes
with flow, or that the regressed parameter is not intrinsic in
nature but contains a small contribution from protein mass-
transfer effects.
The goal of this work, however, is not to understand that
dependence further, but rather to determine if the ZRM
configured for the production-scale capsule with geometry
parameters from Table II can be used to predict BTCs in that
Figure 5. Model-based scale-up for 1mg/mL BSA at 1.2MV/min: (a) best fit of
two-zone ZRM to non-binding BTC of lab-scale capsule, (b) best fit of one-zone ZRM
with given velocity distribution to non-binding BTC of production-scale capsule, (c)
best fit to of spreading model combined with two-zone ZRM with fixed PFR and CSTR
parameters to binding BTC of lab-scale capsule, and (d) predicted and measured
binding BTC of production-scale capsule.
Figure 6. Model-based scale-up for 1mg/mL BSA at 4MV/min: (a) best fit of two-
zone ZRM to non-binding BTC of lab-scale capsule, (b) best fit of one-zone ZRM with
given velocity distribution to non-binding BTC of production-scale capsule, (c) best fit
to of spreading model combined with two-zone ZRM with fixed PFR and CSTR
parameters to binding BTC of lab-scale capsule, and (d) predicted and measured
binding BTC of production-scale capsule.
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preparative-scale unit using parameters for the spreading
model (Table III) determined using the scaled-down system.
Using that approach, we applied the ZRM configured for the
XT140 capsule to predict breakthrough curves for BSA under
binding conditions at flow rates of 1.2MV/min (Fig. 5d) and
4MV/min (Fig. 6d) within that capsule. Both predictions are
in excellent quantitative agreement with experiment. The
preparative-scale ZRM not only predicts the point of
breakthrough, but also the complex tailing of the BTC as
membrane saturation is approached. These predictive results
for the full-scale system using binding parameters collected in
a scaled-down system are highly relevant for industrial
process development, as they prove that binding and
breakthrough studies at preparative or pilot scales using
potentially scarce and likely expensive pure product are not
needed for model development. Instead, any convenient and
inexpensive tracer molecule can be applied to define the
precise flow non-idealities and thereby configure the ZRM for
each scaled unit. Product binding studies conducted in the
small-scale unit may then be used to determine all remaining
model parameters.
The success of the presented method absolutely depends
on the ability of the ZRM to quantitatively decouple band-
broadening effects caused by non-ideal flow and non-ideal
binding, which are both unavoidable in MC capsules.
Binding parameters can only be transferred across scales if
this condition is met by the ZRMs configured at the two
scales. Finally, the results obtained validate our finding that
the linear velocity distribution through membrane in the
production-scale capsule is indeed independent of the
applied volumetric flow rate.
Model-Based Scale-Up for Ovalbumin
To determine if the scale-up approach described is generally
applicable, we next applied it to the same capsules but using a
different protein, ovalbumin, at a flow rate of 5.7MV/min.
The ZRM configurations, binding parameter determination
and scale-up methodology remained the same as described
above. The resulting PFR and CSTR parameters, as shown in
Table IV, are in accordance with those obtained with BSA.
Moreover, BTCs under non-binding conditions are again
reproduced with high accuracy (Fig. 7a and b).
As for BSA, binding of ovalbumin on the PES membrane
was quantitatively reproduced andmost coherently described
by the spreading model (Francis et al., 2011, 2012). Table V
shows the binding parameters for ovalbumin determined in
the scaled-down unit at a flow rate of 5.7MV/min. Using
those parameters, the ZRM for the XT5 capsule accurately
represents ovalbumin breakthrough behavior in that scaled-
down system (Fig. 7c).
The ZRM for the production-scale capsule, with the
geometric parameters from Table IV, was then combined
with the spreading model and binding parameters from
Table V to predict the binding BTC of ovalbumin at 5.7MV/
min. As with BSA, the model prediction and measured
BTC data are in excellent agreement (Fig. 7d). Both the
initial breakthrough point and the approach to saturation
of the BTC are quantitatively predicted by the model. The
results obtained therefore validate the potential generality of
our proposed scale-up method, as well as, our finding that
the linear velocity distribution through membrane in the
production-scale capsule is not only independent of the
applied volumetric flow rate but also of the tracer molecule.
Discussion and Conclusions
The use of scaled-down models of preparative units is a
proven strategy for saving material and time in process
development. However, few resources are currently available
to apply that strategy to MC scale-up. In general,
manufacturers of preparative-scale MC units also sell low-
volume units that utilize the same membrane chemistry, but
Table I. Geometry parameters of symmetric two-zone ZRM of lab-scale
capsule operated at different flow rates, as regressed from BTC data
measured using 1mg/mL BSA under non-binding conditions.
Parameter 1.2MV/min 4MV/min 12MV/min
tlag (s) 31.38 7.38 3.91
tinner (s) 12.02 5.78 1.24
touter (s) 22.54 6.60 1.69
Table II. Geometry parameters of one-zone ZRM of production-scale
capsule operated at different flow rates, as regressed from BTC data
measured using 1mg/mL BSA under non-binding conditions.
Parameter 1.2MV/min 4MV/min 12MV/min
tlag (s) 90.50 29.22 9.70
tupstream (s) 27.89 9.02 2.99
tdownstream (s) 4.85 1.56 0.52
Table III. Binding parameters, as estimated by fitting spreading model
combined with two-zone ZRM to BTC data of lab-scale capsule
measured using 1mg/mL BSA under binding conditions.
Parameter 1.2MV/min 4MV/min 12MV/min
ka1 (1/(g s)) 0.90 102 2.67 102 8.08 102
kd1 (1/s) 1.06 105 1.06 105 1.06 105
k12 (1/(g s)) 7.37 104 7.37 104 7.37 104
k21 (1/s) 8.02 103 9.41 103 9.41 103
qm (g/L) 288.8 290.3 289.0
b () 1.14 1.14 1.14
The 12MV/min data are taken from the first paper of this series (Ghosh
et al., 2012).
Table IV. Geometry parameters of symmetric two-zone ZRM of lab-
scale capsule and of one-zone ZRM of production-scale capsule
operated at a flow rate of 5.7MV/min, as regressed from BTC data
measured using 1mg/mL ovalbumin under non-binding conditions.
Parameter Lab-scale Parameter Production-scale
tlag (s) 4.40 tlag (s) 23.90
tinner (s) 3.08 tupstream (s) 5.80
touter (s) 3.31 tdownstream (s) 0.89
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not the same membrane arrangement nor the same inlet and
outlet flow manifold design. For example, the lab-scale Pall
Mustang XT5 capsule utilizes an axial flow design and a 5mL
stack of flat-sheet membranes, while the preparative Pall
Mustang XT140 capsule utilizes a radial flow design and a
140mL membrane stack presented in a pleated-sheet
arrangement. Thus, while the low-volume XT5 capsule is
well suited for routine laboratory separation needs, it is not
designed specifically for process scale-up studies. This fact is
demonstrated in Figure 1, which shows that normalized
BTCsmeasured at the two scales differ, notably above ca. 60%
saturation.
Here, however, we have shown that results obtained on the
geometrically and operationally distinct lab-scale XT5 MC
unit can nevertheless be used to accurately predict expected
performance in a preparative XT140 unit through application
of the ZRM. This is achieved by precisely configuring the
ZRM to each unit, thereby permitting contributions to band
broadening related to the unique flow non-idealities within
each device to be estimated. Those contributions in the
scaled-down unit can then be subtracted from overall
breakthrough behavior in that unit. The residual defines
intrinsic binding non-idealities common to both units,
allowing binding parameters obtained from low-cost studies
on the scaled-down unit to be directly applied in the ZRM
configured for the preparative unit. The present contribution
therefore provides proof of concept that the ZRM enables
model-based scale-up by conceptually decoupling and
independently quantifying the mechanisms of inhomoge-
neous flow and non-ideal binding inMC capsules at different
scales and operating conditions.
In a separate publication, we have shown that CFD
provides an alternative means to achieve this required
decoupling of non-idealities (Ghosh et al., 2013b). However,
CFD simulations are computationally expensive and require
detailed information on the internal capsule geometry, which
can be difficult to acquire. The ZRM is a semi-empirical
approach with the same predictive power. It requires
estimation of geometry parameters from BTC data for an
inexpensive tracer loaded under non-binding conditions.
That same information can instead be obtained using CFD
models. However, the ZRM approach offers the clear
advantage that it is computationally very fast and does not
require precise information on internal capsule geometries.
Unlike CFD modeling, the ZRM cannot estimate the
distribution of linear velocities through the membrane of a
given preparative MC unit. However, we show here for the
XT140 unit that this distribution is independent of the
applied flow rate and tracer molecule used. Consequently,
the required distribution can be determined once and for all
from only one production scale experiment at binding
conditions using a cheap tracer molecule.
The presented work was supported by the Cluster for Industrial
Biotechnology (CLIB) with a doctoral scholarship for Pranay Ghosh,
as well as by NSERC, the Natural Sciences and Engineering Research
Council of Canada.
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